Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

NCT00602082

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations
  • Basildon University Hospital Basildon, England, United Kingdom
  • Addenbrooke's Hospital Cambridge, England, United Kingdom
  • Cookridge Hospital Leeds, England, United Kingdom
  • Leicester Royal Infirmary Leicester, England, United Kingdom
View all 17 locations
View Trial Details
Completed

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

NCT00690430

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +8 more
Locations
  • Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service Scottsdale, Arizona, United States
  • University of Arizona / Arizona Cancer Center Tucson, Arizona, United States
  • Loma Linda University Dept. of Loma Linda CancerCent Loma Linda, California, United States
  • Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

NCT00496860

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +66 more
Locations
  • University of Colorado, Anschutz Cancer Pavillion Aurora, Colorado, United States
  • MD Anderson Cancer Center Orlando Orlando, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Washington, Seattle Cancer Care Center Seattle, Washington, United States
View Trial Details
Completed

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

NCT00466687

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

NCT00815607

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Santa Monica, California, United States
  • Helen F. Graham Cancer Center Newark, Delaware, United States
  • • Nancy N. and J.C. Lewis Cancer Center & Research Pavilion at St. Joseph/Candles Savannah, Georgia, United States
  • Oncology Specialists, S.C. Park Ridge, Illinois, United States
View Trial Details

Related conditions